Spark Biopharma
Clinical trials sponsored by Spark Biopharma, explained in plain language.
-
New hope for advanced cancer patients? early trial of SB17170 begins
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called SB17170 in about 50 people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects, while also looking for signs that the drug might …
Phase: PHASE1 • Sponsor: SPARK Biopharma • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Recruiting nowThis study tests an experimental drug called SB17170 in 30 adults with moderate to severe idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. Participants take either the drug or a placebo daily for 12 weeks. The main goal is to see if th…
Phase: PHASE2 • Sponsor: SPARK Biopharma • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC